June 18, 2024 at 5:37 pm

The GLP-1 Gold Rush Continues

A 2024 report from GlobalData has revealed that in spite of approaching headwinds in the obesity market, glucagon-like peptide-1 (GLP-1) receptor agonists will continue to… [Read More]